Conservative Management of Patent Ductus Arteriosus Is Feasible in the Peri-Viable Infants at 22-25 Gestational Weeks.

Yang, Misun; Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Jo, Heui Seung; Park, Won Soon

Yang, Misun; Chang, Yun Sil; Ahn, So Yoon; Sung, Se In; Jo, Heui Seung; Park, Won Soon.

Afiliação

Yang M; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Chang YS; Cell and Gene Therapy Institute, Samsung Medical Center, Seoul 06351, Republic of Korea.
Ahn SY; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
Sung SI; Cell and Gene Therapy Institute, Samsung Medical Center, Seoul 06351, Republic of Korea.
Jo HS; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea.
Park WS; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.

Biomedicines ; 11(1)2022 Dec 28.

Article em En | MEDLINE | ID: mdl-36672586

Palavras-chave

conservative management; fluid restriction; patent ductus arteriosus; preterm infant

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google